Navigation Links
DME in Medical News

DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME

ATLANTA, Oct. 17 /PRNewswire/ -- After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has recommended that the pivotal Phase 3 clinical trial FAME(TM) (Fluocinolone Acetonide in Diabetic Macular Edema) Study continue un...

Fastrack Release First Integrated HME Billing, Infusion Pharmacy & Home Care Agency Software in a Microsoft Environment

...HEALTHCARE SYSTEMS announced today the availability of the first integrated dme Billing, Infusion Pharmacy Billing & Home HealthCare Agency Billing Sof...HEALTHCARE SYSTEMS announced today the availability of the first integrated dme Billing, Infusion Pharmacy Billing & Home HealthCare Agency Billing Sof...

Cancer treatment controls macular edema related to diabetes and to cataract surgery

...ma (DME), swelling and thickening of the macula in the retina's center. Laser treatment is usually able to reduce vision loss, but widespread, diffuse dme (DDME) is often resistant to laser and other standard treatments. Treating DMME with bevacizumab (Avastin), an anti-vascular endothelial growth fac...

Fastrack Automates Workflow For Homecare Providers

...grated homecare solutions for Home Medical Equipment providers, Infusion Pharmacy and Home Healthcare Agencies. The Fastrack HME Billing Software and dme Billing Software were the first Windows/SQL based systems. The addition of their IV Billing Software and Home Care Billing Software provides the indu...

NACDS Urges Clarifications, Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation

...onsored by Representative Frank Pallone, which proposed a multiplier of 300% and is clearly key to appropriate pharmacy reimbursement. Access to dme Supplies and Services: We appreciate the legislation's recognition of the importance of patient access to healthcare products in addition to prescrip...

CareFusion Expands Pyxis(R) Perioperative Solutions Offering

...reStation(TM) RFID system(1) Pyxis ProcedureStation(TM) system with Tissue and Implant module Pyxis SupplyStation((R)) system with Biomet dme solution Pyxis((R)) StockStation(TM) system Pyxis((R)) JITrBUD system with Ergotron mobile cart solution Pyxis SupplyRoller((R)) sy...

Upstate HomeCare Expands, Adds Pharmacies

...es provider specializing in infusion, specialty medication, respiratory and dme services, is expanding. Two new pharmacies in Rochester, NY have opened. On...es provider specializing in infusion, specialty medication, respiratory and dme services, is expanding. Just this year they have added two pharmacies in Ro...

Emdeon Acquires eRx Network, LLC

...bility services, value-proven pre- and post-editing, claims reconciliation, resubmission services, electronic prescribing solutions, Medicare/Medicaid dme billing, Medicare Flu billing, Medicare denial management services, and Medicare/Medicaid eligibility verification. About Emdeon Emdeon is a ...

The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer

... scooters, lifts, ramps, and accessories in 48 states and Puerto Rico. The SCOOTER Store has an estimated 30 percent of the current U.S. market in the dme industry and is accredited by the Accreditation Commission for Health Care . The goal of The SCOOTER Store is to create an opportunity for every Am...

InfuSystem Receives Accreditation from the Community Health Accreditation Program (CHAP)

...equired by the Centers for Medicare and Medicaid Services (CMS) to obtain accreditation by September 30, 2009 in order to retain their Medicare Part B dme supplier number allowing them to submit claims for reimbursement. Mr. Steve Watkins, Chief Executive Officer, commented, "Here at InfuSystem, w...
DME in Medical Technology

Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout

ATLANTA, April 8 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that an independent Data Safety Monitoring Board (DSMB) has recommended...

DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME

ATLANTA, Sept. 24 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that after completing its review of safety and efficacy data curre...

DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME

ATLANTA, March 24 /PRNewswire/ -- After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME(TM) (Fluocinolone Acetonid...

Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting

...inical outcomes. A total of 37 subjects with dme were randomized, 20 patients on the low dose of Il... the treatment of diabetic macular edema, or DME. dme is a disease of the retina, which affects individu... trials for the use of Iluvien in the treatment of dme conducted across the U.S., Canada, Europe and Indi...

Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion

...ar form of Age-related Macular Degeneration (wet AMD) and a Phase 2 study in patients with Diabetic Macular Edema (DME). Enrollment in the wet AMD and dme studies is expected to be completed later this year. "Although CRVO is a leading cause of blindness, there is currently no treatment available t...

Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study

...rmation on the safety and efficacy of Iluvien in a dme patient population. A total of 37 subjects were e...son, in published results from clinical studies of dme patients using sustained release intravitreal FA i...utive Officer of Alimera Sciences. In the Retisert dme trials, visual acuity continued to improve over th...

ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)

... retinopathy, due to their underlying medical condition. The MIVI II dme trial is a Phase II, randomized, double masked, sham injection controlled, ...od vessels within the macula. The only approved treatment for patients with dme is laser photocoagulation; however, this treatment does not improve vision ...

Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study

...for the treatment of diabetic macular edema (DME). dme is a disease of the retina, which affects individu...rmation on the safety and efficacy of Iluvien in a dme patient population. A total of 37 subjects were en...r the treatment of diabetic macular edema, or DME. dme is a disease of the retina, which affects individu...

Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study

...l insert being developed for the treatment of DME. dme is a disease of the retina, which affects individu...r the treatment of diabetic macular edema, or DME. dme is a disease of the retina, which affects individu... trials for the use of Iluvien in the treatment of dme conducted across the U.S., Canada, Europe and Indi...

Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema

...fer real medical value to both physicians and patients." Investigators for this open-label, dose-escalation study will treat patients suffering from dme with a single intravitreal injection (inside the eye) of CORTIJECT(R) formulation. The trial will include 3 treatment arms with patients receiving one...
DME in Biological News

Coal and black liquor can produce energy from papermaking

... The final product looked at by the researchers is dme or dimethyl ether. "DME could be used as a fuel...ing coal for home heating and cooking in China." dme is building new markets in both heat producing fue...a third generation experimental truck that runs on dme and other companies are also testing vehicles. "...
DME in Biological Technology

Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings

ATLANTA, Oct. 22 /PRNewswire/ -- Contour Products(TM), a leader in the sleep support and ergonomic body comfort industry, is introducing three exciting cash-and-carry products for the home health market: the new Contour CPAP Pillow that offers outstanding comfort and freedom to mask users; the...

ThromboGenics NV: Business Update

...Macular Edema (DME). In March 2009, ThromboGenics completed the enrolment for a Phase II trial of microplasmin intravitreal injection for treatment of dme (MIVI II DME). This trial is designed as the initial step in evaluating the utility of microplasmin in patients with diabetes, a group which is more p...

Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD

...ich is being developed for the treatment of diabetic macular edema, or DME. dme is a disease of the retina, which affects individuals with diabetes and can...07 in two Phase 3 pivotal trials for the use of Iluvien in the treatment of dme conducted across the U.S., Canada, Europe and India, with a combined total ...

Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions

...nitiating a Phase 2 clinical trial of sirolimus in dme and preparing to initiate a Phase 2 study in wet A...ase 1 clinical trials in patients with wet AMD and dme have shown MacuSight's proprietary formulation of ...ondition develops, central vision becomes blurred. dme can progress fairly rapidly and over just a few ye...

Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement

...ake and consolidate the development and commercialization of our late stage dme product Medidur FA," said Dan Myers, President and CEO of Alimera Sciences....ar area. In the United States, as many as 200,000 people are diagnosed with dme each year and an estimated 1,000,000 people suffer from DME. Currently ther...

ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting

...while diabetic macular edema (DME) is the leading cause of decreased vision in patients with diabetic retinopathy. Around 750,000 patients suffer from dme in the United States alone. About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceutical...

ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007

...as also started a MIVI-II Phase IIa trial in Europe to evaluate microplasmin injection for the non-surgical treatment of diabetic macular edema (DME). dme is a complication of diabetic retinopathy and is in fact the leading cause of vision loss in diabetic retinopathy patients. MIVI-II (DME) is a Phase ...

Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers

...zed proteasome inhibitor) was prepared by dissolving in DMSO to a concentration of 10 mM. The HEK 293 ZsGreen Proteasome Sensor Cells were cultured in dme + 10% FBS + 1% Pen/ Strep/L-glutamine + 200 g/mL of G418. They were seeded overnight in 100 L at a density of 30,000 cells/well in a Costar black-wall...

measurement of green fluorescent proteins and a red fluorescent protein in live cells in the Analyst GT multimode reader

...Reader (Molecular Devices) METHODS Cell preparation and analysis The cells were cultured in bulk flasks in dme + 10% FBS + 1% Pen/Strep/L-glutamine + 500 g/mL of G418. Non-transfected HEK cells were included as controls. The night before the experiment, they we...
DME in Biological Products

Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich

Description:...cations of Eagle's medium have been developed since the original formulation. The most widely used modification is Dulbecco's Modified Eagle's Medium. dme is a modification of Minimum Essential Medium Eagle [MEM] that contains a higher concentration of vitamins and amino acids, as well as additional supp...
Company:Sigma-Aldrich
Other Tags
(Date:9/17/2014)... (PRWEB) September 17, 2014 A recent ... fiscal year 2010 revealed 3.2% of these patients developed surgical ... 2.4% labeled as superficial SSIs. The average difference for each ... after adjustments. , The study, conducted by Marin Schweizer, PhD, ... University of Iowa, found the treatment costs for the hospitals ...
(Date:9/17/2014)... In ongoing coverage of formulary exclusion ... (DBN) continues to find criticism surrounding the tactic. ... issue , CVS Caremark Corp. and Express Scripts ... cut more drugs than ever, but industry consultants ... likely to achieve. Despite finding the strategy problematic, ...
(Date:9/17/2014)... Representatives with Capitol Pain Institute ... Anti-Defamation League Event at the Four Seasons in Austin, Texas. ... an honor to be a sponsor for this great event,” ... Schocket went on to explain that the event, the Torch ... and members at the Four Seasons to honor Torch of ...
(Date:9/17/2014)... September 17, 2014 The Mount ... Westchester, Putnam and Dutchess Counties in New York, ... affiliation agreement with the Mount Sinai Health System, ... integrated and coordinated care for the communities they ... Mount Sinai and MKMG will work together to ...
(Date:9/17/2014)... Washington, DC (PRWEB) September 17, 2014 ... family history. Along with regular screening and examination, a ... In this episode of Epicure with the Chef ... GWMFA Urologist Dr. Paul Rusilko to prepare a delicious ... in our western diets that influence risk of prostate ...
Breaking Medicine News(10 mins):Health News:Three Ways to Minimize Costs Associated with Surgical Site Infections 2Health News:AIS Newsletter Continues to Find Industry Criticism of PBM Formulary Exclusion Lists 2Health News:AIS Newsletter Continues to Find Industry Criticism of PBM Formulary Exclusion Lists 3Health News:Capitol Pain Institute Sponsoring an Anti-Defamation League Event & Awards Dinner 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 3Health News:Boost Prostate Health with Epicure with the Chef MDs 2
(Date:9/17/2014)... R.I. [Brown University] After decades of decline, grasses ... saltmarshes. To the eye, the marsh in those places ... that a key service of the marsh coastal ... back but the ecosystem function hasn,t come back," said ... senior author of the study in the journal ...
(Date:9/17/2014)... been growing significantly faster since the 1960s. The typical ... but they have accelerated -- by as much as ... carried out by scientists from Technische Universitt Mnchen based ... been continuously observed since 1870. Their findings were published ... ago, "forest dieback" was a hot topic, with the ...
(Date:9/17/2014)... United Kingdom forms a new crime unit designed to ... last year over horse meat being passed off as ... for detecting meat adulteration. They describe their approach, which ... Journal of Agricultural and Food Chemistry . , ... a major global economic problem. But they also say ...
Breaking Biology News(10 mins):Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3Global change: Trees continue to grow at a faster rate 2Global change: Trees continue to grow at a faster rate 3
Other Contents